Purpose of Technology
Continuous glucose monitoring (CGM) systems are minimally invasive or noninvasive devices that measure glucose levels in interstitial fluid at frequent intervals over a period of several days. CGM systems are designed to obtain information regarding daily patterns in glucose levels that, when evaluated in real time or reviewed retrospectively by a physician, can guide adjustments to therapy, with the goal of improving overall glycemic control. The glucose measurements provided during continuous monitoring are not intended to replace standard self-monitoring of blood glucose (SMBG) obtained using fingerstick blood samples, but can alert the patient to the need to perform SMBG.
Relevant Questions
-
Does the information obtained from CGM systems used in conjunction with SMBG improve short-term glycemic outcomes and long-term health outcomes in adults with type 1 or type 2 diabetes?
-
Does the information obtained from CGM systems used in conjunction with SMBG improve short-term glycemic outcomes and long-term health outcomes in pediatric and adolescent patients with type 1 or type 2 diabetes?
-
Does the information obtained from CGM systems used in conjunction with SMBG improve short-term glycemic outcomes, pregnancy outcomes, and long-term health outcomes in pregnant women with type 1, type 2, or gestational diabetes, and in their children?
-
Are CGM systems safe?
-
Have definitive patient selection criteria been established for CGM systems?
If you have a Hayes login, click here to view the full report on the Knowledge Center.